Russia To Fund $4 Million Trials Of Cleveland BioLabs Stem Cell Booster
This article was originally published in PharmAsia News
Executive Summary
Russia’s Ministry of Industry and Trade reached a $4 million agreement with U.S.-based Cleveland BioLabs to form an alliance to develop a drug intended to stimulate the growth of stem cells.